Pentagalloyl Glucose from <i>Bouea macrophylla</i> Suppresses the Epithelial–Mesenchymal Transition and Synergizes the Doxorubicin-Induced Anticancer and Anti-Migration Effects in Triple-Negative Breast Cancer
<b>Background:</b> Triple-negative breast cancer (TNBC) represents an aggressive form of breast cancer with few available therapeutic options. Chemotherapy, particularly with drugs like doxorubicin (DOX), remains the cornerstone of treatment for this challenging subtype. However, the cli...
Saved in:
| Main Authors: | Jiraporn Kantapan, Phattarawadee Innuan, Sarawut Kongkarnka, Padchanee Sangthong, Nathupakorn Dechsupa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/17/12/1729 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Amyloid Aggregation Effects of Gobaishi (<i>Galla chinensis</i>) and Its Active Constituents
by: Sharmin Akter, et al.
Published: (2025-06-01) -
Potentiating doxorubicin activity through BCL-2 inhibition in p53 wild-type and mutated triple-negative breast cancer
by: Anna R. Schreiber, et al.
Published: (2025-04-01) -
POC1A induces epithelial–mesenchymal transition to promote growth and metastasis through the STAT3 signaling pathway in triple-negative breast cancer
by: Yuzhou Qian, et al.
Published: (2025-08-01) -
USP51/GRP78/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells
by: Yang Ou, et al.
Published: (2025-05-01) -
Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancer
by: Tatiane da Silva Fernandes, et al.
Published: (2025-01-01)